Connect Biopharma Limite... (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

0.84

0.02 (2.44%)

At close: May 02, 2025, 11:38 AM

Connect Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-15.63M	-59.38M	-116.12M	-204.94M	-119.37M	-24.46M
Depreciation & Amortization	660K	988K	1.01M	640.98K	221.05K	114.61K
Stock-Based Compensation	6.73M	3.26M	1.01M	1.41M	590.64K	562.17K
Other Working Capital	-12.83M	12.72M	6.78M	-5.62M	-719.69K	-425.22K
Other Non-Cash Items	118K	-2.28M	-1.35M	6.91K	443.18K	7.69K
Deferred Income Tax	n/a	n/a	3.37M	106.37M	89.68M	8.3M
Change in Working Capital	-15.49M	9.48M	7.16M	3.27M	-436.29K	2.38M
Operating Cash Flow	-23.61M	-47.93M	-99.27M	-85.57M	-25.61M	-13.09M
Capital Expenditures	-750K	-294K	-4.28M	-7.46M	-2.34M	-155.52K
Cash Acquisitions	n/a	2.94M	79.16K	47.73K	53.46K	329.18
Purchase of Investments	-15.45M	-32.6M	-113.7M	-17.98M	-16.33M	-23.65M
Sales Maturities Of Investments	12.63M	105.19M	34.54M	20.1M	19.12M	23.32M
Other Investing Acitivies	123K	-84K	-79.16K	-47.74K	-53.46K	-329.18
Investing Cash Flow	-3.45M	75.16M	-83.44M	-5.34M	449.15K	-484.7K
Debt Repayment	n/a	-290K	-222K	-126K	-82.42K	-63.6K
Common Stock Repurchased	n/a	n/a	n/a	-566K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	227K	n/a	119K	-19.12M	140.83M	7K
Financial Cash Flow	227K	-246K	-91.29K	206.66M	140.74M	-57.45K
Net Cash Flow	-27.43M	27M	-168.93M	109.42M	107.4M	-13.44M
Free Cash Flow	-24.36M	-48.22M	-103.55M	-93.03M	-27.95M	-13.25M